本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tempest Therapeutics Inc.

10.14
-0.9500-8.57%
盤後10.890.7475+7.37%19:50 EDT
成交量:8.14萬
成交額:85.43萬
市值:4,502.32萬
市盈率:-0.73
高:11.15
開:11.09
低:10.09
收:11.09
52周最高:15.73
52周最低:5.35
股本:444.02萬
流通股本:416.38萬
量比:1.21
換手率:1.95%
股息:- -
股息率:- -
每股收益(TTM):-13.9218
每股收益(LYR):-19.4955
淨資產收益率:-322.57%
總資產收益率:-81.34%
市淨率:4.60
市盈率(LYR):-0.52

資料載入中...

2024/10/10

重要事件披露

Form 8-K - Current report
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments